Keck Medical Center of USC (Outpatient Clinic) — Los Angeles, California

Public research footprint of Keck Medical Center of USC (Outpatient Clinic), compiled from the ClinicalTrials.gov public registry.

146

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Locally Advanced Ureter Urothelial Carcinoma · Recurrent Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma · B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1 · Stage III Bladder Urothelial Carcinoma AJCC v6 and v7

Recently updated registry entries

NCT06081894 — A Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Placebo in Adults… (Active Not Recruiting)
NCT02523014 — Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients… (Recruiting)
NCT02194738 — Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Keck Medical Center of USC (Outpatient Clinic)?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 06, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.